ENVB (Enveric Biosciences, Inc. Common Stock) Stock Analysis - SEC Filings

Enveric Biosciences, Inc. Common Stock (ENVB) is a publicly traded Healthcare sector company. As of May 21, 2026, ENVB trades at $2.19 with a market cap of $4.27M and a P/E ratio of -0.16. ENVB moved +6.16% today. Year to date, ENVB is -45.41%; over the trailing twelve months it is -86.42%. Its 52-week range spans $1.71 to $99.90. Rallies surfaces ENVB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find ENVB SEC filings?

Rallies organizes ENVB SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

ENVB Key Metrics

Key financial metrics for ENVB
MetricValue
Price$2.19
Market Cap$4.27M
P/E Ratio-0.16
EPS$-13.36
Dividend Yield0.00%
52-Week High$99.90
52-Week Low$1.71
Volume927
Avg Volume0
Revenue (TTM)$-411
Net Income$-8.22M
Gross Margin0.00%

Latest ENVB News

Recent ENVB Insider Trades

  • PASQUALONE FRANK bought 1.00K (~$2.14K) on Sep 15, 2023.

ENVB Analyst Consensus

ENVB analyst coverage data. Average price target: $0.00.

Common questions about ENVB

Where can I find ENVB SEC filings?
Rallies organizes ENVB SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show ENVB 10-K and 10-Q filings?
Rallies organizes ENVB SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is ENVB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ENVB. It does not provide personalized investment advice.
ENVB

ENVB